IRCT2013071313069N2
Completed
Phase 3
Comparison of therapeutic effects of metformin, pioglitazone and vitamin E on nonalcoholic fatty liver disease patients
Vice chancellor for research, Kermanshah University of Medical Sciences0 sites93 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- onalcoholic fatty liver disease.
- Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Enrollment
- 93
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age above 18 year and Non\-alcoholic fatty liver disease alone with negative hepatitis serology
- •Exclusion criteria: clinical manifestation of liver disease, icter, steroid and alcohol use, diabetes, pregnancy, hypothyroidism, renal failure.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of metformin, pioglitazone and vitaminE E in patients with non-alcoholic fatty liver diseasenon-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT2016010411991N3Vice chancellor for research,Kermanshah University of Medical Sciences93
Completed
Not Applicable
Comparison of therapeutic effects of metformin and simvastatin in PCOSPCOS.Polycystic ovarian syndromeIRCT201012285487N2Alzahra Hospital Research Center60
Not yet recruiting
Phase 3
Investigation of the effect of metformin gel on severe chronic periodontitisIRCT20200623047900N1Zahedan University of Medical Sciences50
Recruiting
Phase 3
Effect of metformin and L-carnitine in treatment of fatty livernon alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20150706023083N3Tabriz University of Medical Sciences68
Recruiting
Phase 3
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50